Target
Serine/threonine-protein kinase 26
Ligand
BDBM451741
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
>1000±n/a nM
Citation
 Gray, NSBuhrlage, SAnderson, KCottini, FTonon, G STK4 inhibitors for treatment of hematologic malignancies US Patent  US10710978 Publication Date 7/14/2020 
Target
Name:
Serine/threonine-protein kinase 26
Synonyms:
MASK | MST4 | STK26 | STK26_HUMAN | Serine/threonine-protein kinase MST4
Type:
PROTEIN
Mol. Mass.:
46517.68
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1510631
Residue:
416
Sequence:
MAHSPVAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWKAEGHSDDESDSEGSDSESTSRENNTHPEWSFTTVRKKPDPKKVQNGAEQDLVQTLSCLSMIITPAFAELKQQDENNASRNQAIEELEKSIAVAEAACPGITDKMVKKLIEKFQKCSADESP
  
Inhibitor
Name:
BDBM451741
Synonyms:
N-(4-(6-amino-5-(1-oxo- 1,2,3,4-tetrahydroisoquinolin- 6-yl)pyridin-3-yl)-3- fluorophenyl) cyclopropanesulfonamide | US10710978, Compound I-51
Type:
Small organic molecule
Emp. Form.:
C23H21FN4O3S
Mol. Mass.:
452.501
SMILES:
Nc1ncc(cc1-c1ccc2C(=O)NCCc2c1)-c1ccc(NS(=O)(=O)C2CC2)cc1F
Structure:
Search PDB for entries with ligand similarity: